国际检验方法对促进产品质量提高的启示

对氨基二苯胺是性能优异的对苯二胺类防老剂的中间体。其质量好坏直接关系到防老剂4020、4010NA、688等品种的质量。对氨基二苯胺质量检验方法的提出则有助于我们开拓思路，更新质量观念，地症下药，分析原因，采取措施，全面提高其内在质量。     

基于曲线进化的目标检测算法

提出了基于曲线进化的运动目标检测算法。对于运动目标检测问题定义了新颖的能量模型,并给出了相应的曲线进化方程。结合水平集算法,所提出的曲线进化模型能够自动的适应拓扑变化,检测出多个运动目标区域及轮廓。从计算物理学领域引入基于偏微分方程的水平集窄带算法,在构造窄带时无需显示的知道曲线的位置,并能够快速的实现。     

主动约束层阻尼板结构动力学建模研究

将有限元法和GHM法相结合，给出了建立主动约束层阻尼（ACLD）板结构动力学模型的新方法。建模时，考虑到粘弹材料（VEM）的纵向位移影响，采用GHM方法描述VEM的本构关系，解决了VEM的力学特性随温度和频率变化的难点，避免因VEM的复杂本构关系而产生的微分积分方程。算例表明本文给出的建模方法是准确的，ACLD结构能够有效控制结构振动。     

纤维素酶分子的计算机辅助序列分析

利用生物大分子数据库（EMBL、SWALL和PDB）及软件技术（DNASIS和AntheProt）对嗜热子囊菌（Thermoascus aurantiacus)的产生的一种纤维素酶分子进行了序列分析及结构预测；通过多种来源的纤维素酶的比较研究，分析了其催化区、活性位点及局部保守序列。     

挡土墙填土曲线破裂面的地震主动土压力分析

在地震作用影响下，墙后填土处于极限平衡状态时，假定破裂面为一条通过墙趾的旋轮线。从墙后土楔中取出一微薄水平层，研究其在水平惯性力下的平衡，得到的地震土压力分布和土压力合力作用点位置均与实验结果相吻合。     

X波段双极化有源相控阵天线的设计

机载或星载X波段有源相控阵雷达系统具有很高的分辨率，由于雷达系统使用了大量双极化子阵组成的有源相控阵天线（俯仰面和方位面均需扫描），频率的升高使得子阵馈线网络的可用面积受到了很大的限制。本文着重论述了有源相控阵天线中的双极化阵设计，提出了一系列解决方法，进而叙述了整个天线阵的设计。     

InGaAsP/InP有源双稳放大器的实验研究

本文报导了室温下F—P型InGaAsP/InP双异质结半导体激光放大器的双稳态效应,放大器的增益为20dB。     

STN—LCD的新进展

STN-LCD采用新的取向层,消除了残象;采用新的驱动波形,消除了串扰;采用二(口恶)烷、卤化物、链烯基、醚和二苯乙炔,改进了液晶料材的性能,使STN-LCD获得高的对比度、快的响应速度、低的驱动电压;采用有源矩阵驱动方法,消除了帧响应,使STN-LCD获得高的对比度、高的亮度及视频响应速度;使用温度跟踪电路,自动跟踪STN-LCD的阀值电压,使STN-LCD获得宽的工作温度。     

CAD OF MILLIMETER WAVE OSCILLATORS WITH THE FDHB TECHNIQUE

In this paper the modelling, analysis and optimization of millimeter wave oscillatorsare investigated by using the a frequency-domain harmonic balance technique (FDHB), where theexternal-circuit impedances looking outside from the active device are calculated with a combinedtechnique of modes expansion, Galerkin, and collocation methods. The optimization results arein agreement with the experimental ones, which show the reliability of the presented model andoptimization.     

Structure-activity studies of human tumour necrosis factors

The mechanism by which tumour necrosis factors (TNF and lymphotoxin,also called TNFß and TNFß respectively) exerttheir cytotoxic activity on many malignant cells, remains largelyunknown. Furthermore, the broad array of differentiation (geneinduction) and mitogenic activities towards many primary cellsis still a subject of intensive investigation. TNF is an importantmediator in inflammation, immune responses and infection-relatedphenomena and these activities contribute to the severe toxidtyseen when TNF is used as an anticancer agent. The first stepin the mechanism of action is the specific binding of the ligandto its receptors and dissection of the molecular mechanism involvedin this interaction is the subject of this review. The reasonsfor the interest in this aspect are obvious: first, the developmentof strong antagonistic TNF analogues can be useful in dampeningthe potentially lethal or debilitating effects of an overproductionof the cytokine (as in septic shock or rheumatoid arthritis).Secondly, since two distinct TNF receptors exist, constructionof TNF muteins that distinguish between both types may leadto derivatives of this plekrtropic agent with a more restrictedbiological activity pattern. Ideally, one would like to developa TNF mutant that has retained its cytotoxic action on tumourcells without inducing the deleterious systemic toxteity. Suchan optimized TNF molecule could become a potent anticancer agent